Anavex Life Sciences Corp (AVXL)

[falconer66a]

Too Early for an Anavex Press Release

The time to take advantage [by a big Anavex announcement] is after the full AD trial data is in and Anavex can SHOW there is a valid theoretical approach to AD. And, more importantly, there is now a treatment for AD.

Steady, exactly.

Were Missling and Anavex to turn right around and on Monday make a big announcement, "Amyloid thesis now dead for Alzheimer's; we have the real solution," Anavex would instantly get lumped in with all the companies that promoted (with billions of dollars spent on research and clinical trials) the induced removal of amyloid accumulations. In every case a complete failure.

None of the pharmaceutical biggies could solve the Alzheimer's problem, after spending decades of time and billions of dollars. Obviously (to most), Alzheimer's is a complicated CNS disease for which there cannot be a simple, orally dosed pill that could ever treat the disease. Just who does Anavex think we, the biotech investment market, are? We know better. Anavex, with its 'barkameseen,' is barking up the wrong tree. Big Pharma can't fix Alzheimer's. Brand new little Anavex has even a smaller chance.

So, yes, as always before, the only thing that will change the game, for both Alzheimer's patients and Anavex Life Sciences Corp will be incontrovertible clinical results, showing with statistical significance that blarcamesine beats the existing SOC (standard of care) Alzheimer's drugs.